Search

This article discusses the incidence and risk factors for malignancies in patients who have undergone heart transplantation at a single center. The study analyzed data from 296 patients who had undergone heart transplantation between September 2010 and August 2023. The overall incidence of malignancy was 8.8%, with skin cancer being the most common type. The study found that the switch to everolimus as part of the immunosuppression therapy did not reduce the incidence of malignancies. Early detection through close follow-up is important for improving the prognosis of these malignancies. [Extracted from the article]

This article discusses the use of temporary mechanical circulatory support (TMCS) as a bridge-to-transplant strategy for patients with cardiogenic shock who require a heart transplant. The study included 296 patients who underwent heart transplant, with 14 of them being on TMCS at the time of transplantation. The TMCS patients had higher rates of postoperative circulatory failure and mortality compared to patients without TMCS. The study highlights the complexity and critical preoperative state of TMCS patients and suggests that while heart transplantation is possible for these patients, their outcomes may be impaired. [Extracted from the article]